EL FINANCIAL STATEMENTS

EssilorLuxottica S. A. — balance sheet, income statement and cash flow trends

ELEssilorLuxottica S. A.

🇫🇷 France · PA · Healthcare · Medical Instruments & Supplies

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q2 2025 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue28.5 B €+12.2%

Gross Profit17.3 B €+7.3%

Operating Income3.4 B €+2.0%

EBITDA6.5 B €+5.9%

Net Income2.3 B €+1.1%

Peer Comparison· Medical Instruments & Supplies

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
EL	7.5%	60.6%	23.0%	8.1%
ISRG	21.4%	66.3%	40.8%	28.2%
BDX	2.4%	46.5%	21.9%	5.3%
RMD	10.3%	61.7%	39.5%	27.4%
WST	11.2%	36.2%	26.2%	16.9%
RMD	10.5%	61.2%	39.1%	27.4%
Industry median	6.4%	53.7%	13.8%	3.9%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q2 2025

Equity38.9 B €61%
Current Liabilities12.2 B €19%
Long-term Liabilities12.3 B €19%

Key Figures

YoY change

Total Assets63.9 B €+5.6%

Total Liabilities24.4 B €+12.8%

Total Equity38.9 B €+1.7%

Cash & ST Investments3.5 B €+38.5%

Total Debt14.4 B €+23.5%

Net Debt10.9 B €+19.3%

Peer Comparison· Medical Instruments & Supplies

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
EL	0.99	37.0%	1.66	60.9%
ISRG	6.03	—	—	86.9%
BDX	0.94	71.6%	3.51	47.5%
RMD	3.01	13.0%	-0.37	73.9%
WST	2.71	10.6%	-0.24	72.8%
RMD	3.01	13.0%	-0.38	73.9%
Industry median	2.40	34.8%	1.44	62.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q2 2025 · TTM

Key Figures

YoY change

Operating Cash Flow5.3 B €+8.8%

Capital Expenditures1.5 B €-0.4%

Free Cash Flow3.8 B €+13.1%

Dividends Paid0 €-100.0%

Peer Comparison· Medical Instruments & Supplies

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
EL	18.6%	13.2%	5.4%	228.6%
ISRG	31.8%	26.8%	5.0%	112.8%
BDX	18.3%	14.7%	3.6%	342.8%
RMD	34.1%	31.6%	2.6%	124.4%
WST	22.2%	14.2%	8.0%	131.8%
RMD	34.2%	31.7%	2.5%	124.8%
Industry median	13.8%	8.6%	3.8%	128.3%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on EL

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 8, 26. This content is for informational purposes only and is not investment advice.